Literature DB >> 1535736

Markers of procoagulant imbalance in patients with inherited thrombophilic syndromes.

P M Mannucci1, A Tripodi, B Bottasso, F Baudo, G Finazzi, V De Stefano, G Palareti, C Manotti, M G Mazzucconi, G Castaman.   

Abstract

In 107 asymptomatic and untreated patients with inherited syndromes associated with thrombophilia (antithrombin III, protein C and protein S deficiencies), we compared in parallel two plasma peptides which reflect activation of the common coagulation pathway: the prothrombin fragment 1 + 2 (F1 + 2) and fibrinopeptide A (FPA). Both F1 + 2 and FPA were measured with simple, commercially available ELISA methods. High levels of F1 + 2 or FPA were found in about one fourth of the patients as a whole. When patients were divided according to the type of inherited thrombophilic syndrome, it appeared that F1 + 2 was more frequently elevated in protein C and protein S deficiencies than in antithrombin deficiency; and that, in general, it was no more frequently elevated than FPA. Although our data confirm the existence of a procoagulant imbalance in inherited thrombophilic syndromes due to defects of natural anticoagulant proteins, they do not confirm that such imbalance can be more frequently diagnosed by measuring F1 + 2 levels, particularly in patients with antithrombin deficiency.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1535736

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  6 in total

1.  Laboratory Measurement of Thrombin Activity--What Every Clinician Scientist Needs to Know.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1995       Impact factor: 2.300

2.  Markers of thrombin and plasmin generation in patients with inherited thrombophilia.

Authors:  L H Lee; I Jennings; R Luddington; T Baglin
Journal:  J Clin Pathol       Date:  1994-07       Impact factor: 3.411

Review 3.  Thrombophilia: how far should a clotter be investigated?

Authors:  I D Walker
Journal:  Postgrad Med J       Date:  1994-06       Impact factor: 2.401

Review 4.  Warfarin withdrawal. Pharmacokinetic-pharmacodynamic considerations.

Authors:  G Palareti; C Legnani
Journal:  Clin Pharmacokinet       Date:  1996-04       Impact factor: 6.447

5.  No Prognostic Importance of Resistance to Activated Protein C in Unstable Coronary Artery Disease Despite Signs of Thrombin Activation.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1998       Impact factor: 2.300

6.  FV Leiden mutation and risk of recurrent venous thromboembolism in Serbian population.

Authors:  Mirjana Kovac; Danijela Mikovic; Nebojsa Antonijevic; Ljiljana Rakicevic; Valentina Djordjevic; Dragica Radojkovic; Ivo Elezovic
Journal:  J Thromb Thrombolysis       Date:  2007-06-05       Impact factor: 2.300

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.